|
|
| 华润医药集团有限公司, 03320.HK - 综合现金流量表 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
| 经营活动之现金流量 |
10,005,684 |
10,078,563 |
6,726,586 |
6,298,917 |
7,745,011 |
5,879,023 |
5,596,379 |
| 投资回报及融资费用之现金流量 |
-4,888,117 |
-6,072,803 |
-3,753,631 |
-3,590,254 |
-2,736,815 |
-3,003,486 |
-2,609,904 |
| 已收利息 |
697,948 |
716,102 |
253,959 |
264,949 |
163,849 |
126,816 |
122,440 |
| 已付利息 |
-3,614,790 |
-2,835,035 |
-2,115,904 |
-1,704,876 |
-1,963,397 |
-2,071,343 |
-1,852,193 |
| 已收股息 |
29,960 |
56,701 |
11,479 |
8,660 |
14,245 |
29,273 |
6,519 |
| 已付股息 |
-2,001,235 |
-4,010,571 |
-1,903,165 |
-2,158,987 |
-951,512 |
-1,088,232 |
-886,670 |
| 其他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 退回/(已缴)税项 |
-1,864,745 |
-1,831,598 |
-1,869,048 |
-2,179,270 |
-1,756,221 |
-1,692,301 |
-1,494,222 |
| 投资活动之现金流量 |
280,884 |
-10,573,805 |
-8,777,005 |
-2,226,669 |
-4,097,316 |
-8,135,177 |
-5,917,680 |
| 增添固定资产 |
-1,596,697 |
-1,522,238 |
-1,566,712 |
-1,719,816 |
-1,286,895 |
-2,018,684 |
-2,264,478 |
| 出售固定资产 |
91,506 |
27,993 |
67,775 |
197,243 |
148,246 |
184,314 |
117,300 |
| 投资增加 |
-36,088,349 |
-23,381,042 |
-10,778,744 |
-18,787,025 |
-18,920,498 |
-16,069,670 |
-7,926,137 |
| 投资减少 |
39,214,938 |
16,987,934 |
3,410,762 |
18,842,073 |
17,441,469 |
10,942,936 |
2,952,398 |
| 与关联人士之现金流量 |
9,830,253 |
-167,496 |
-844,111 |
-2,261,717 |
-1,065,972 |
-218,189 |
-1,121,469 |
| 其他 |
-11,170,767 |
-2,518,956 |
934,025 |
1,502,573 |
-413,666 |
-955,884 |
2,324,706 |
| 融资活动前之现金流量 |
3,533,706 |
-8,399,643 |
-7,673,098 |
-1,697,276 |
-845,341 |
-6,951,941 |
-4,425,427 |
| 融资活动之现金流量 |
-7,393,828 |
11,513,049 |
7,145,940 |
3,238,405 |
1,360,626 |
6,249,887 |
6,747,532 |
| 新增贷款 |
55,823,978 |
76,973,500 |
60,079,512 |
30,677,481 |
45,255,902 |
42,841,249 |
26,650,865 |
| 偿还贷款 |
-73,837,312 |
-67,933,640 |
-46,319,111 |
-42,284,110 |
-43,452,513 |
-37,004,423 |
-27,750,110 |
| 定息/债项工具融资 |
7,487,353 |
7,976,123 |
0 |
5,263,007 |
2,491,369 |
1,893,750 |
3,686,232 |
| 偿还定息/债项工具 |
-6,698,100 |
-5,335,438 |
-5,770,350 |
-2,923,625 |
-1,868,160 |
-1,262,500 |
0 |
| 股本融资 |
0 |
0 |
0 |
14,767,369 |
0 |
0 |
5,282,014 |
| 与关联人士之现金流量 |
9,830,253 |
-167,496 |
-844,111 |
-2,261,717 |
-1,065,972 |
-218,189 |
-1,121,469 |
| 其他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| 现金及等同现金之增加/(减少) |
-3,860,122 |
3,113,406 |
-527,158 |
1,541,129 |
515,285 |
-702,054 |
2,322,105 |
| 年初之现金及现金等同项目 |
16,636,337 |
14,174,734 |
13,972,252 |
13,214,946 |
13,735,944 |
15,175,387 |
12,693,625 |
| 外汇兑换率变动之影响/(其他) |
-228,074 |
-651,803 |
729,640 |
-783,823 |
-1,036,283 |
-737,389 |
159,657 |
| 年终之现金及现金等同项目 |
12,548,141 |
16,636,337 |
14,174,734 |
13,972,252 |
13,214,946 |
13,735,944 |
15,175,387 |
| 货币 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
港元 |
| 单位 |
| 核数师意见 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
说明：1代表无保留意见；2代表保留意见；3代表修改意见
|
|
